Novavax vs. Medicago NVAX â Further Dive On Medicago Acquisition Emphasizes How Undervalued Novavax Is â REITERATE BUY On July 12, Medicago (MDG) announced intentions to be acquired by Japanâs Mitsubishi Tanabe Pharmaceuticals (MTP), valuing the company at $376 million (including the assumption of $32 million of net debt). Comparing this price with the Novavax[…]
To access this post, you must have an active subscription to the Medical Technology Stock Letter. Please login if you are a current subscriber. Thank you.